Stocktoria

Armata Pharmaceuticals, Inc. ARMP

NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1994-05-20 · LEI

Armata Pharmaceuticals, Inc. statistics & valuation

Market cap$237.2M
Return on capital-53.9%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-193.70% -52.70% -217.10% -133.50% -117.60% -91.20% -102.30% 2016201720182019202020212022202320242025
Shares outstanding
1.6M 9.5M 5.1M 9.9M 18.7M 27.1M 36.1M 36.1M 59.1M 36.4M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-103.80% -115.30% -114.80% -76.50% -56.10% -33.20% -38.50% -70.20% -21.90% -226.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$24.67 -$2.18 -$3.59 -$2.55 -$1.35 -$0.96 -$1.08 -$1.91 -$0.89 -$4.80 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-226.1%-21.9%-70.2%-38.5%-33.2%-56.1%-76.5%-114.8%-115.3%-103.8%
Return on equity79.5%39.4%215.3%-102.3%-91.2%-117.6%-133.5%-217.1%-52.7%-193.7%
Current ratio1.190.231.161.093.111.621.365.102.741.78

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.